Atlas Trials

A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT06999031 · RECRUITING

Trial details

NCT number
NCT06999031
Sponsor
The First Affiliated Hospital of Nanchang University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Relapsed/RefractoryMultiple Myeloma
Start date
2024-09-05
Primary completion
2026-04-05
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.